An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome

Clinical trial NCT02036853 · COMPLETED

Trial details

NCT number: NCT02036853
Sponsor: Adrian Lacy
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)

Start date: 2014-02-20
Primary completion: 2019-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.